Katz Barrett
SEC CIK 1841628 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VRDN | Viridian Therapeutics, Inc.\DE | Chief Medical Off | 4,147 | — | $3.17M | 4 | 2023-01-09 | 2023-01-13 |
Most active insiders at VRDN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Fairmount Funds Management LLC | Dir, 10% | $20.00M | — |
| 2 | Fairmount Healthcare Fund II GP LLC | Dir, 10% | $10.00M | — |
| 3 | Tousignant Jennifer | CLO | — | $419.0K |
| 4 | Harmon Seth | CFO | — | — |
| 5 | Tripuraneni Radhika | Chief Medical Off | — | — |
| 6 | Mahoney Stephen F. | Pres, CEO, Dir | — | — |
| 7 | Beetham Thomas W. | COO | — | — |
Katz Barrett made no open-market trades at VRDN in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-01-18 | 2023-01-13+ | VRDN | Viridian Therapeutics, Inc.\DE | Katz Barrett | Chief Medical Off | M - OptEx | $23.03 | +29.0K | 4,147 | New | +$667.9K |
| DM | 2023-01-18 | 2023-01-13+ | VRDN | Viridian Therapeutics, Inc.\DE | Katz Barrett | Chief Medical Off | S - Sale+OE | $37.18 | -29.0K | 0 | -100% | -$1.08M |
| DM | 2023-01-11 | 2023-01-09+ | VRDN | Viridian Therapeutics, Inc.\DE | Katz Barrett | Chief Medical Off | M - OptEx | $23.03 | +60.0K | 47.4K | New | +$1.38M |
| DM | 2023-01-11 | 2023-01-09+ | VRDN | Viridian Therapeutics, Inc.\DE | Katz Barrett | Chief Medical Off | S - Sale+OE | $34.82 | -60.0K | 0 | -100% | -$2.09M |
Purchase Sale Sale after option exercise All abbreviations